Inotiv, Inc. (NOTV) P/E Ratio History
Deep ValueTrading at -0.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 1998–2018
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, Inotiv, Inc. (NOTV) trades at a price-to-earnings ratio of -0.0x, with a stock price of $0.08 and trailing twelve-month earnings per share of $-2.51.
The current P/E is 100% below its 5-year average of 63.9x. Over the past five years, NOTV's P/E has ranged from a low of 11.7x to a high of 328.8x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.0x, NOTV trades at a 100% discount to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 191.4x.
Relative to the broader market, NOTV trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our NOTV DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
NOTV Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
NOTV P/E vs Peers
Contract Research and Preclinical Services peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $9B | 29.3 | 1.27 | -25% | |
| $993M | 157.8 | - | +107% | |
| $13B | 58.6 | - | -70% | |
| $15B | 34.5 | 1.08Best | +21% | |
| $1B | 25.3 | - | -4% | |
| $191B | 28.9 | 13.69 | +7% | |
| $138B | 38.8 | - | -5% | |
| $8B | 10.8Lowest | - | +143%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
NOTV Historical P/E Data (1998–2018)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2018 Q3 | Jun 30 2018 | $1.65 | $0.03 | 48.7x | -41% |
| FY2018 Q2 | Mar 31 2018 | $1.60 | $0.07 | 21.9x | -73% |
| FY2018 Q1 | Dec 31 2017 | $2.45 | $0.11 | 21.7x | -74% |
| FY2017 Q4 | Sep 30 2017 | $1.76 | $0.11 | 15.7x | -81% |
| FY2015 Q4 | Sep 30 2015 | $1.69 | $0.07 | 23.8x | -71% |
| FY2015 Q3 | - | $2.01 | $0.11 | 18.3x | -78% |
| FY2013 Q4 | Sep 30 2013 | $1.35 | $0.11 | 12.5x | -85% |
| FY2011 Q2 | - | $2.29 | $0.16 | 14.0x | -83% |
| FY2008 Q2 | Mar 31 2008 | $5.82 | $0.02 | 328.8x | +300% |
| FY2008 Q1 | Dec 31 2007 | $8.67 | $0.08 | 115.0x | +40% |
| FY2007 Q4 | Sep 30 2007 | $6.96 | $0.19 | 36.9x | -55% |
| FY2007 Q3 | Jun 30 2007 | $7.23 | $0.08 | 90.4x | +10% |
| FY2006 Q2 | Mar 31 2006 | $6.30 | $0.04 | 168.4x | +105% |
| FY2005 Q1 | Dec 31 2004 | $5.00 | $0.07 | 73.6x | -10% |
| FY2003 Q4 | - | $4.30 | $0.02 | 187.0x | +127% |
| FY2003 Q3 | Jun 30 2003 | $2.80 | $0.10 | 26.7x | -67% |
| FY2003 Q2 | Mar 31 2003 | $2.98 | $0.09 | 33.9x | -59% |
| FY2003 Q1 | - | $2.73 | $0.23 | 11.7x | -86% |
| FY2002 Q4 | Sep 30 2002 | $3.09 | $0.22 | 13.8x | -83% |
| FY2002 Q3 | Jun 30 2002 | $5.15 | $0.32 | 16.1x | -80% |
| FY2002 Q2 | Mar 31 2002 | $6.90 | $0.37 | 18.6x | -77% |
| FY2002 Q1 | Dec 31 2001 | $7.01 | $0.39 | 18.0x | -78% |
| FY2001 Q4 | Sep 30 2001 | $5.84 | $0.38 | 15.4x | -81% |
| FY2001 Q3 | Jun 30 2001 | $8.95 | $0.18 | 49.0x | -40% |
| FY2001 Q2 | Mar 31 2001 | $3.03 | $0.04 | 71.8x | -13% |
| FY2000 Q1 | Dec 31 1999 | $2.56 | $0.03 | 83.1x | +1% |
| FY1999 Q4 | - | $3.06 | $0.12 | 26.3x | -68% |
| FY1999 Q3 | Jun 30 1999 | $3.94 | $0.01 | 703.6x | +755% |
| FY1999 Q2 | Mar 31 1999 | $3.63 | $0.03 | 141.8x | +72% |
| FY1999 Q1 | - | $3.94 | $0.04 | 110.7x | +35% |
| FY1998 Q4 | Sep 30 1998 | $5.38 | $0.09 | 62.9x | -24% |
| FY1998 Q3 | - | $7.00 | $0.13 | 52.7x | -36% |
Average P/E for displayed period: 82.3x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
28+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NOTV — Frequently Asked Questions
Quick answers to the most common questions about buying NOTV stock.
What is NOTV's P/E ratio?
Inotiv, Inc. (NOTV) trailing twelve-month P/E ratio is -0.0x, based on TTM diluted EPS of $-2.51. The 5-year average P/E is 63.9x and the historical range spans 11.7x to 328.8x.
Is NOTV stock overvalued or undervalued?
NOTV current P/E: -0.0x. 5-year average P/E: 63.9x. Percentile: 0th.
Is NOTV stock expensive?
NOTV is fairly valued relative to its own history. The current P/E of -0.0x is near the 5-year average of 63.9x (0th percentile of historical range).
What is NOTV's historical P/E range?
Over the past 5 years, NOTV's P/E ratio has ranged from 11.7x to 328.8x, with a median of 26.7x and an average of 63.9x. The current P/E of -0.0x places the stock at the 0th percentile of this range. Full historical data spans 1998–2018.
How does NOTV's P/E compare to the S&P 500?
NOTV current P/E: -0.0x. S&P 500 median P/E: 25.3x.
How does NOTV's valuation compare to Healthcare peers?
Inotiv, Inc. P/E of -0.0x can be benchmarked against Healthcare peers in the comparison table on this page.
What is NOTV's PEG ratio?
NOTV PEG ratio is N/A, based on a P/E of -0.0x and EPS growth of 49.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is NOTV's earnings yield?
NOTV earnings yield is N/A, the inverse of its -0.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.